Skip to main content

Happiest Minds IPO subscribed 8.4 times, retail portion at 39 times

 Ajcon Global believes the issue is priced at a premium owing to its robust business model and major presence in Digital IT space.

The Rs 702-crore initial public offering of Bengaluru-based mid-sized digital IT company Happiest Minds Technologies continues to see strong subscription on the second day of bidding, September 8.

The public issue has received bids for 19.53 crore equity shares against IPO size (excluding anchor book) of 2.3 crore equity shares and as a result, the offer witnessed 8.4 times subscription, the data available on the exchanges showed.

Retail investors maintained their tempo by investing a huge sum of money in the issue as their portion set aside has been subscribed over 38.85 times. The reserved portion of non-institutional investors saw 3.96 times subscription and that of qualified institutional investors 46.7 percent.

The public issue, which will close on September 9, consists a fresh issue of Rs 110 crore and an offer for sale of 3,56,63,585 equity shares by promoter Ashok Soota and JP Morgan-backed private equity fund CMDB II.

The issue price band has been fixed at Rs 165-166 per share.

"At the upper end of the price band of Rs 166, the issue is valued at a P/E of 27x at FY20 EPS at Pre-IPO and at a P/E of 34x on post IPO EPS of Rs 4.88. We believe the issue is priced at a premium owing to its robust business model and major presence in Digital IT space. The recent fancy for companies with differentiated business model instills confidence on this issue. The international peers which have a similar businesses model are trading at a P/E valuation of around 65x," said Ajcon Global report made by Akash Jain, MBA (Financial Markets), Vice – President Research, which recommended subscribing the issue for listing gains.

The brokerage likes the company due to the following factors: a) strong brand in Digital IT services with 97 percent revenues coming from high margin digital space as compared to peers deriving 35-50 percent, b) the global digital services market of $691 billion in 2019 is expected to grow at a CAGR of 20.2 percent to $2 trillion, c) growing high revenue generating customer accounts with a high proportion of repeat revenues and revenues from mature markets," said Ajcon Global report made by Akash Jain, MBA (Financial Markets), Vice – President Research.

The brokerage also cited more strong reasons for its recommendation - Scalable business model with multiple drivers of steady growth; end to end capabilities spanning the digital lifecycle from roadmap to deployment and maintenance; strong R&D capability; agile engineering and delivery; strong promoter - Ashok Soota (erstwhile co-founder of Mindtree); and improved financial performance.

Happiest Minds' business is divided into three business units viz. 1) Digital Business processing 2) Product Engineering Services and 3) Infrastructure management and security services.

The company has already raised Rs 316 crore from 25 anchor investors, including the Government of Singapore, Goldman Sachs, Kuwait Investment Authority, Nomura Funds Ireland, Jupiter India etc.

The company proposed to utilise the net proceeds from the fresh issue towards long term working capital requirement and general corporate purposes.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Brokerages place bets on Titan, see double-digit upside in the stock

Titan can get benefits from the strong market share in the jewellery and wrist watches segment, mainly driven by a wide range of product portfolio catering mainly to the premium and value-added designer jewellery segment. After three consecutive sessions of losses, shares of Titan Company rose over a percent in morning trade on BSE on September 23. The company was dealt a severe blow by COVID-19 as the pandemic triggered strict lockdowns completely battered the retail sector. In the calendar year so far, shares of this one of the largest, most efficient and profitable specialty retailer in India are 7 percent down. The company reported a net standalone loss of Rs 270 crore for the quarter ended June 2020 as the COVID-19 pandemic hit business. The loss was higher than a CNBC-TV18 poll estimate of Rs 175 crore. Standalone revenue during the quarter declined 62.3 percent year-on-year to Rs 1,862 crore compared to the corresponding period last fiscal. Light at the end ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more